PH27122A - N-pyridinyl-9H-carbazol-9-amines and a process for their preparation - Google Patents
N-pyridinyl-9H-carbazol-9-amines and a process for their preparation Download PDFInfo
- Publication number
- PH27122A PH27122A PH39801A PH39801A PH27122A PH 27122 A PH27122 A PH 27122A PH 39801 A PH39801 A PH 39801A PH 39801 A PH39801 A PH 39801A PH 27122 A PH27122 A PH 27122A
- Authority
- PH
- Philippines
- Prior art keywords
- compound
- hydrogen
- pyridinyl
- carbazol
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Hydrogenated Pyridines (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/289,887 US4868190A (en) | 1988-12-27 | 1988-12-27 | N-pyridinyl-9H-carbazol-9-amines |
Publications (1)
Publication Number | Publication Date |
---|---|
PH27122A true PH27122A (en) | 1993-03-16 |
Family
ID=23113557
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH39801A PH27122A (en) | 1988-12-27 | 1989-12-26 | N-pyridinyl-9H-carbazol-9-amines and a process for their preparation |
Country Status (19)
Country | Link |
---|---|
US (1) | US4868190A (cs) |
EP (1) | EP0376155B1 (cs) |
JP (1) | JPH0725749B2 (cs) |
KR (1) | KR900009596A (cs) |
AT (1) | ATE79118T1 (cs) |
AU (1) | AU623205B2 (cs) |
CA (1) | CA2006529C (cs) |
DE (1) | DE68902386T2 (cs) |
DK (1) | DK662189A (cs) |
ES (1) | ES2044043T3 (cs) |
FI (1) | FI896243A7 (cs) |
GR (1) | GR3006140T3 (cs) |
IE (1) | IE894175L (cs) |
IL (1) | IL92867A0 (cs) |
NO (1) | NO895222L (cs) |
NZ (1) | NZ231943A (cs) |
PH (1) | PH27122A (cs) |
PT (1) | PT92696A (cs) |
ZA (1) | ZA899904B (cs) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4916135A (en) * | 1989-05-08 | 1990-04-10 | Hoechst Roussel Pharmaceuticals Inc. | N-heteroaryl-4-quinolinamines |
US5179099A (en) * | 1989-08-02 | 1993-01-12 | Hoechst-Roussel Pharmaceuticals Incorporated | 2,3-dihydro-1-(pyridinylamino)-indoles |
ES2068294T3 (es) * | 1989-08-02 | 1995-04-16 | Hoechst Roussel Pharma | 2,3-dihidro-1-(piridinilamino)-indoles, un procedimiento para su preparacion y su uso como medicamentos. |
US4994472A (en) * | 1989-08-02 | 1991-02-19 | Hoechst-Roussel Pharmaceuticals Incorporated | 1-(pyridinylamino)-2-pyrrolidinones as pain relievers |
US4983608A (en) * | 1989-09-05 | 1991-01-08 | Hoechst-Roussell Pharmaceuticals, Inc. | N-substituted-4-pyrimidinamines and pyrimidinediamines |
NZ312577A (en) * | 1995-07-27 | 1999-08-30 | Hoechst Marion Roussel Inc | Use of optionally substituted n-(pyrrol-1-yl)-pyridinamines as anticonvulsant agents |
US5776955A (en) * | 1995-07-27 | 1998-07-07 | Hoechst Marion Roussel, Inc. | Use of unsubstituted and substituted n-(pyrrol-1-yl)pyridinamines as anticonvulsant agents |
ZA989365B (en) * | 1997-10-15 | 1999-04-15 | Boehringer Mannheim Pharm Corp | Preparation for treating alzheimer's disease |
CN1250213C (zh) * | 2000-07-21 | 2006-04-12 | 奥索-麦克尼尔药品公司 | 用于预防或治疗神经性疼痛和丛集性头痛及有或没有先兆的偏头痛的氨基甲酸酯化合物 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH475982A (de) * | 1966-11-16 | 1969-07-31 | Wander Ag Dr A | Verfahren zur Herstellung von Carbazolderivaten |
EP0073849A1 (en) * | 1981-09-03 | 1983-03-16 | Schering Corporation | Novel phenyl-1,2,3,4-tetrahydrocarbazoles, their preparation and pharmaceutical compositions containing them |
US4792562A (en) * | 1985-12-04 | 1988-12-20 | Hoechst-Roussel Pharmaceuticals, Inc. | N-(pyrrol-1-yl)pyridinamines having memory enhancing activity |
US4752610A (en) * | 1985-12-04 | 1988-06-21 | Hoechst-Roussel Pharmaceuticals Inc. | N-(pyrrol-1-yl)pyridinamines having memory enhancing properties |
ATE115143T1 (de) * | 1987-04-24 | 1994-12-15 | Hoechst Roussel Pharma | N-(pyridinyl)-1h-indol-1-amine, verfahren zu deren herstellung und ihre verwendung als arzneimittel. |
US4806554A (en) * | 1988-01-11 | 1989-02-21 | Hoechst-Roussel Pharmaceuticals, Inc. | Pyrazol and indazolpyridinamines |
US4916135A (en) * | 1989-05-08 | 1990-04-10 | Hoechst Roussel Pharmaceuticals Inc. | N-heteroaryl-4-quinolinamines |
ES2068294T3 (es) * | 1989-08-02 | 1995-04-16 | Hoechst Roussel Pharma | 2,3-dihidro-1-(piridinilamino)-indoles, un procedimiento para su preparacion y su uso como medicamentos. |
US5006537A (en) * | 1989-08-02 | 1991-04-09 | Hoechst-Roussel Pharmaceuticals, Inc. | 1,3-dihydro-1-(pyridinylamino)-2H-indol-2-ones |
-
1988
- 1988-12-27 US US07/289,887 patent/US4868190A/en not_active Expired - Lifetime
-
1989
- 1989-12-21 ES ES89123612T patent/ES2044043T3/es not_active Expired - Lifetime
- 1989-12-21 NZ NZ231943A patent/NZ231943A/en unknown
- 1989-12-21 EP EP89123612A patent/EP0376155B1/en not_active Expired - Lifetime
- 1989-12-21 DE DE8989123612T patent/DE68902386T2/de not_active Expired - Fee Related
- 1989-12-21 IE IE894175A patent/IE894175L/xx unknown
- 1989-12-21 AT AT89123612T patent/ATE79118T1/de not_active IP Right Cessation
- 1989-12-22 CA CA002006529A patent/CA2006529C/en not_active Expired - Fee Related
- 1989-12-22 PT PT92696A patent/PT92696A/pt unknown
- 1989-12-22 DK DK662189A patent/DK662189A/da not_active Application Discontinuation
- 1989-12-22 AU AU47203/89A patent/AU623205B2/en not_active Ceased
- 1989-12-22 FI FI896243A patent/FI896243A7/fi not_active Application Discontinuation
- 1989-12-22 NO NO89895222A patent/NO895222L/no unknown
- 1989-12-25 IL IL92867A patent/IL92867A0/xx unknown
- 1989-12-26 PH PH39801A patent/PH27122A/en unknown
- 1989-12-26 KR KR1019890019472A patent/KR900009596A/ko not_active Withdrawn
- 1989-12-26 JP JP1335256A patent/JPH0725749B2/ja not_active Expired - Fee Related
- 1989-12-27 ZA ZA899904A patent/ZA899904B/xx unknown
-
1992
- 1992-11-04 GR GR920402184T patent/GR3006140T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0376155A1 (en) | 1990-07-04 |
ZA899904B (en) | 1991-02-27 |
DK662189A (da) | 1990-06-28 |
PT92696A (pt) | 1990-06-29 |
DE68902386T2 (de) | 1993-02-11 |
NO895222L (no) | 1990-06-28 |
KR900009596A (ko) | 1990-07-05 |
IE894175L (en) | 1990-06-27 |
JPH02247173A (ja) | 1990-10-02 |
DK662189D0 (da) | 1989-12-22 |
ATE79118T1 (de) | 1992-08-15 |
AU623205B2 (en) | 1992-05-07 |
CA2006529A1 (en) | 1990-06-27 |
NZ231943A (en) | 1992-06-25 |
FI896243A7 (fi) | 1990-06-28 |
US4868190A (en) | 1989-09-19 |
IL92867A0 (en) | 1990-09-17 |
JPH0725749B2 (ja) | 1995-03-22 |
CA2006529C (en) | 1999-08-10 |
NO895222D0 (no) | 1989-12-22 |
AU4720389A (en) | 1990-07-05 |
EP0376155B1 (en) | 1992-08-05 |
ES2044043T3 (es) | 1994-01-01 |
FI896243A0 (fi) | 1989-12-22 |
GR3006140T3 (cs) | 1993-06-21 |
DE68902386D1 (de) | 1992-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SU1181540A3 (ru) | Способ получени сульфамоилзамещенного производного фенэтиламина и его кислотной соли | |
DE69233401T2 (de) | Verbrückte zyklische polyamine mit anti-hiv wirkung | |
DE69831233T2 (de) | Barbitursaure derivaten mit antimetastatischer und antitumorischer wirkung | |
SA99200064B1 (ar) | مشتقات إيميدازو بيريدين imidazo pyridine المثبطة لإفراز الحمض المعدي acid secretion | |
CZ253594A3 (en) | Pharmaceutical composition for inhibiting proliferation of saponaceous muscle and restenosis | |
KR20010014215A (ko) | 항전이활성을 갖는 비스-인돌 유도체, 그의 제조방법 및그를 함유하는 약제학적 조성물 | |
PH27122A (en) | N-pyridinyl-9H-carbazol-9-amines and a process for their preparation | |
FI87648B (fi) | Foerfarande foer framstaellning av terapeutiskt aktiv 8-halogen-11-(4-piperidyliden)-6,11-dihydro-5h-bentso/5,6/cyklohepta/1,2-b/-pyridin | |
DE68921298T2 (de) | Herzschützende tocopherolähnliche Verbindungen. | |
KR0179063B1 (ko) | 항정신병 작용을 갖는 화합물 | |
IE922264A1 (en) | Novel compounds | |
KR900006722B1 (ko) | 항불안제 | |
AU623098B2 (en) | Esterified azacyclic hydroxy compounds | |
PH26080A (en) | Novel antihypertensive benzopyran derivatives | |
SU1545941A3 (ru) | Способ получени оксотиазолидиновых соединений | |
EP0494754A1 (en) | 3-hydroxypyridin-4-one derivatives as pharmaceutical compositions | |
RU2001126348A (ru) | 4-гетероциклилсульфонамидил-6-метокси-5-(2-метоксифенокси)-2-пиридил пиримидиновые производные и фармацевтическая композиция | |
US6767919B2 (en) | High specificity anticancer agents | |
DE60002395T2 (de) | Metalloproteaseinhibitoren, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen | |
WO1999036068A1 (fr) | Activateurs des canaux de potassium | |
CN101300243A (zh) | 邻位取代苯胺衍生物和抗氧化药 | |
PL132131B1 (en) | Process for preparing novel derivatives of 1,2,4-oxadiazolin-5-one | |
EP0660821B1 (en) | Non-metabolizable clomiphene analogs for treatment of tamoxifen-resistant tumors | |
US4305938A (en) | 2,8-Disubstituted-10-hydroxy-5,5-dimethyl-tetrahydro-and hexahydro-5H-[1]-benzopyrano[4,3-c]pyridines, compositions and use | |
EP0003286B1 (de) | Ergopeptidalkaloid-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen |